ABSTRACT Skin lesions have been identified in 20 workers manufacturing 4,4'-bipyridyl. The lesions were on the face, neck, and backs of the hands and arms. Larger localised lesions were removed surgically and examined histopathologically, but 
During 1976 several shift process operators in the 4,4'-bipyridyl plant at Widnes were found to be suffering from various skin lesions on the hands, forearms, and sometimes the scalp. We describe the comprehensive study to identify the extent of this problem and the probable cause and the continuing health surveillance programme.
Methods

IDENTIFICATION OF POPULATION AT RISK
In 1976 all 158 personnel working in the plant (which manufactures 4,4'-bipyridyl for use in paraquat
Received 8 June 1981 Accepted 5 August 1981 production) were exam;ned clinically by the work's medical officer. Twelve shift process operators were referred to a consultant dermatologist, who confirmed that 11 had skin lesions described askeratoses, including one with an epithelioma. As all patients had also worked on the previous 4,4'-bipyridyl plants, it was decided to follow up all personnel who had worked on the plants since manufacture started in 1961.
The names of all workers associated with manfacture of 4,4'-bipyridyl or its subsequent conversion to paraquat and the packing of paraquat solutions were obtained from employee records and personal recall by those working in various jobs on different units. Individuals were traced from personnel files, Premaligniant and neoplastic skin lesions associated with occupational exposure to "tarry" byproducts pension records, voters' lists, and personal contact. Two discontinued processes (high temperature sodium (HTS) and magnesium (MAG)) and one existing process (low temperature sodium (LTS)) have been used to manufacture 4,4'-bipyridyl at Widnes. Little information on quantitative occupational hygiene is available from the early plants, but descriptions of the processes and conditions of work were obtained from plant personnel who knew of conditions on all three plants. CLINICAL 
AND MORTALITY STUDIES
All those traced were offered a medical examination, but a few said that they had no skin problems and declined it. They were classified as "informed with no skin lesions" ( A more detailed survey of shift process operators was undertaken. Data on the plants on which they worked, the period they had worked on the plants ("service times"), the period since first starting work on a 4,4'-bipyridyl plant ("elapsed time") (table 2) and the time between starting working on the plant and the appearance of lesions ("years to onset from first exposure") (table 3) were obtained from the medical and occupational records.
In an attempt to look for a link between skin disorders and a particular plant area or job the work histories of 24 plant shift operators who worked on both the MAG and the LTS processes were analysed in detail to obtain the period worked in the various areas of the plant.
INVESTIGATING SUBSTANCES ON THE PLANTS FOR EVIDENCE OF CARCINOGENICITY AND MUTAGENICITY
A list of 99 identifiable chemicals used in the three processes was prepared, and publications and company records were searched to identify any substances with known carcinogenic properties.
Representative process chemicals were tested for potential carcinogenicity in the Salmonella reverse mutation assay1 and cell transformation assay.23 A laboratory rig was set up to produce samples by the discontinued MAG process and samples were selected from the current LTS process.
HEALTH MONITORING
A continuing health monitoring programme was 
No not traced No contacted = Number "examined" plus the number "informed with no skin lesions." HTS = High temperature sodium. MAG = Magnesium. LTS = Low temperature sodium. Three processes have been used to produce 4,4'-bipyridyl at Widnes. The chemistry used in the three processes is essentially the same in that pyridine is dimerised to a reduced species that is then oxidised to 4,4'-bipyridyl.
The reaction conditions used and efficiency of conversion differ, however, and hence the nature and quantities of the resultant byproducts differ. After isolation the 4,4'-bipyridyl is quaternised with methyl chloride (also dimethyl sulphate in 1961-9) to give a 1,1'-dimethyl-4,4'-bipyridylium (paraquat) salt (fig).
The magnesium process plant (1962-7) also consisted of several batch operations; there were more stages and more recycling of materials. The conversion efficiency of pyridine to 4,4'-bipyridyl was somewhat higher than in the HTS plant, but a considerable amount and variety of byproducts such as bipyridyl isomers, terpyridyls, polypyridyls, and large amounts of similar insoluble tars were formed.
Exposure for both process operators and maintenance personnel was much higher than on the HTS plant, mainly due to process difficulties. There was additional handling of intermediate chemicals. Tarry deposits formed blockages in pipework and equipment, which often had to be dismantled to remove the tars by using steam lances and rodding equipment. These activities and the batch nature of the process led to relatively poor conditions of hygiene. Skin contact with the non-corrosive process materials was a problem, and there was exposure to vapours.
The low temperature sodium plant, which has operated since 1966, converts pyridine to 4,4'-bipyridyl with almost 1000% efficiency. The process materials are well contained in a continuous, automated plant, mainly operated remotely from a control room. Exposure of process operators and maintenance personnel is low. Skin contact is minimal because the chemicals are not handled in the process, and protective equipment is worn during sampling and maintenance. In addition measured concentrations of process materials such as 4,4'-bipyridyl and pyridine in the plant atmosphere are very low. Table 3 shows a variation in the estimated period to onset of the skin disorder from first exposure associated with 4,4'-bipyridyl plant of from six to 19 years, with an average of 12 years. In many of the cases time of onset is only judged by individual worker recollection and therefore can only be approximate: keratosis may well have been present for some time before being noticeable. The effect of age on latent period was considered, but no significant correlation was found between "years to onset of disorder" and "age when first exposed."
A more detailed survey of the shift process operators is given in table 2. They are grouped according to the plant, or combination of plants, on which they worked. Twenty-six long-serving shift process operators worked on both the MAG and LTS plants, transferring to the LTS plant when the MAG plant was shut down. Most cases have occurred in this group. Of the remaining patients, one worked on the HTS plant only, one on the MAG plant only, and the other two worked on all three plants. The HTS plant was located at a separate works, and fewer men transferred from there to the MAG or LTS plants.
Average service times and elapsed times since first exposure on a 4,4'-bipyridyl plant are given for comparison with the information on cases given in table 3.
In an attempt to look for a link between the skin disorders and a particular plant area or job the work histories of 24 MAG and LTS plant shift operators were analysed in detail to obtain the period worked in various areas of the MAG and LTS plants. Most operators had worked in various areas, and analysis showed no significant correlations.
INVESTIGATION OF SUBSTANCES PRESENT IN THE PLANTS
Six carcinogens or potential carcinogens were identified from the survey of publications, and five of these (benzene, hexavalent chromium, methyl chloride, methylene chloride, and dimethyl sulphate) were not known skin carcinogens, nor was there a history of skin contact. The sixth, mineral oil, has been associated with the induction of skin cancer in man4 and was used on all three plants for engineering purposes. Modern oils are solvent refined, reducing their contamination with carcinogens, and again there was no history of excessive skin contamination of the affected process operators. There were no other chemicals with potential carcinogenic properties, and for many (including paraquat) there was good evidence of the absence of carcinogenicity in suitable laboratory experiments.
Forty-four samples were tested in the Salmonella assay and 12 of them in the cell transformation assay. Unequivocally positive results were obtained with three samples to which the affected workers were exposed:
(a) A solvent extract containing tars and polypyridyl byproducts derived from the MAG process yielded five fractions that were positive in the Salmonella test.
(b) The unfractionated tars were toxic to Salmonella, giving negative results, but were positive in the cell transformation assay. The shift process operators on the MAG plant had been extensively exposed to these solvent and tar mixtures.
(c) 4,4'-bipyridyl was positive in the cell transformation, but not the Salmonella assay. It was not likely to be the cause of the lesions since only one case occurred among HTS plant process operators, whose exposure to 4,4'-bipyridyl was considered to be highest of the workers on the three processes. Nevertheless, a life-time mouse skin painting programme is being carried out to obtain further information on the toxicity of 4,4'-bipyridyl.
Negative results were obtained in both assays for other chemicals to which the workers were exposed. In particular, paraquat is negative in both in-vitro assays and in long-term carcinogenicity assays. The workers who pack paraquat and spray operators have been examined, and no evidence of similar skin lesions has been found.5
Discussion
The keratoses and other lesions seen in the 20 workers are clinically and pathologically indistinguishable from those produced in fair-skinned people by prolonged exposure to sunlight (solar keratosis), or occurring in the elderly (senile keratosis). The most likely explanations for the lower incidence in the group of 18 is that they had low service times on the MAG plant, part of which was training, and almost all then left the company. By contrast, the group of 26 who transferred to the LTS plant had been the most exposed group on the MAG plant.
The survey of publications on the potential carcinogenicity of the chemicals used on the plants failed to identify any chemicals that could have caused the lesions. In-vitro assays carried out on various samples from the MAG and LTS processes have identified a solvent extract, used in the MAG process, that contained polypyridyls and tars, with activity indicative of potential carcinogenicity.
The information from occupational histories, occupational exposure descriptions, and the in-vitro test led to the conclusion that the substance most probably responsible for the skin lesions was the tarry byproduct present in the solvent extract from the MAG process. Similar tarry deposits were present in the HTS, but not the LTS, process, and exposure to these deposits is presumed to be the cause of the skin lesions in the HTS process operator. None of the other chemicals, including paraquat, is a likely cause of the skin lesions. Since the MAG and HTS processes have been discontinued, it seems unlikely that the substance that caused the lesions will ever be conclusively established. Nevertheless, it is clearly prudent to take steps to minimise exposure to chemicals in all other processes for making 4,4'-bipyridyl or that are likely to produce polypyridyls, and to continue to monitor the health of the workers. 
